Aug 19 2025 eGenesis Appoints Douglas Williams , Ph.D., and Adam Craig, M.D., Ph.D., to its Board of Directors Company
Sep 04 2024 eGenesis Raises $191 Million Series D Financing to Advance Lead Program for Kidney Transplant Company
Feb 13 2024 eGenesis and PorMedTec Announce Successful Production of Genetically Engineered Porcine Donors in Japan Kidney Company
Oct 25 2023 eGenesis Presents Preclinical Data Demonstrating Recipient Survival and Compatibility with Genetically Engineered Porcine Kidneys at 2023 IPITA-IXA-CTRMS Joint Conference Company
Oct 10 2023 eGenesis Announces Publication in Nature of Landmark Preclinical Data Demonstrating Long-Term Survival with Genetically Engineered Porcine Kidneys Company
Jun 13 2023 eGenesis Announces Publication in Nature Communications Characterizing Renal Physiology and Endocrine Function in Non-Human Primates Post Xenograft Transplant Company
Jan 09 2023 eGenesis and Eledon Pharmaceuticals Announce Collaboration for Use of Tegoprubart in Preclinical Xenotransplantation Studies Company Partnerships
Mar 09 2022 eGenesis Announces Research Collaboration with the University of Miami to Evaluate Human Compatible Islet Cells in Diabetes Model Company Partnerships